129 related articles for article (PubMed ID: 26334617)
1. G648C variant of DNA polymerase β sensitizes esophageal cancer to chemotherapy.
Wang Y; Sun Q; Guo W; Chen X; Du Y; Zang W; Dong Z; Zhao G
Tumour Biol; 2016 Feb; 37(2):1941-7. PubMed ID: 26334617
[TBL] [Abstract][Full Text] [Related]
2. MiR-499 Enhances the Cisplatin Sensitivity of Esophageal Carcinoma Cell Lines by Targeting DNA Polymerase β.
Wang Y; Feng J; Zang W; Du Y; Chen X; Sun Q; Dong Z; Zhao G
Cell Physiol Biochem; 2015; 36(4):1587-96. PubMed ID: 26159783
[TBL] [Abstract][Full Text] [Related]
3. Roles of GST-π and polβ genes in chemoresistance of esophageal carcinoma cells.
Tang Y; Xuan XY; Li M; Dong ZM
Asian Pac J Cancer Prev; 2013; 14(12):7375-9. PubMed ID: 24460306
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of A613T and G462T variants of DNA polymerase β weakens chemotherapy sensitivity in esophageal cancer cell lines.
Wang Y; Chen X; Sun Q; Zang W; Li M; Dong Z; Zhao G
Cancer Cell Int; 2016; 16():85. PubMed ID: 27843412
[TBL] [Abstract][Full Text] [Related]
5. Clinical significance of a point mutation in DNA polymerase beta (POLB) gene in gastric cancer.
Tan X; Wang H; Luo G; Ren S; Li W; Cui J; Gill HS; Fu SW; Lu Y
Int J Biol Sci; 2015; 11(2):144-55. PubMed ID: 25561897
[TBL] [Abstract][Full Text] [Related]
6. Enhancement of silencing DNA polymerase β on the radiotherapeutic sensitivity of human esophageal carcinoma cell lines.
Wang Y; Chen X; Hu X; Zhang R; Du Y; Zang W; Dong Z; Zhao G
Tumour Biol; 2014 Oct; 35(10):10067-74. PubMed ID: 25015190
[TBL] [Abstract][Full Text] [Related]
7. DNA polymerase β mutations and survival of patients with esophageal squamous cell carcinoma in Linzhou City, China.
Li M; Zang W; Wang Y; Ma Y; Xuan X; Zhao J; Liu L; Dong Z; Zhao G
Tumour Biol; 2014 Jan; 35(1):553-9. PubMed ID: 23959474
[TBL] [Abstract][Full Text] [Related]
8. DNA polymerase beta promoter mutations affect gene transcription, translation and the sensitivity of esophageal cancer cells to cisplatin treatment.
Wang T; Zang W; Ma Y; Li M; Xuan X; Wang N; Wu R; Li Y; Dong Z; Zhao G
Mol Biol Rep; 2013 Feb; 40(2):1333-9. PubMed ID: 23117284
[TBL] [Abstract][Full Text] [Related]
9. MiR-149 sensitizes esophageal cancer cell lines to cisplatin by targeting DNA polymerase β.
Wang Y; Chen J; Zhang M; Zhang W; Li M; Zang W; Dong Z; Zhao G
J Cell Mol Med; 2018 Aug; 22(8):3857-3865. PubMed ID: 29726631
[TBL] [Abstract][Full Text] [Related]
10. Mutation of DNA polymerase beta in esophageal carcinoma of different regions.
Zhao GQ; Wang T; Zhao Q; Yang HY; Tan XH; Dong ZM
World J Gastroenterol; 2005 Aug; 11(30):4618-22. PubMed ID: 16094698
[TBL] [Abstract][Full Text] [Related]
11. Enhanced Activity of Variant DNA Polymerase β (D160G) Contributes to Cisplatin Therapy by Impeding the Efficiency of NER.
Wang M; Li E; Lin L; Kumar AK; Pan F; He L; Zhang J; Hu Z; Guo Z
Mol Cancer Res; 2019 Oct; 17(10):2077-2088. PubMed ID: 31350308
[TBL] [Abstract][Full Text] [Related]
12. DNA polymerase β deficiency promotes the occurrence of esophageal precancerous lesions in mice.
Qin J; Zhu Y; Ding Y; Niu T; Zhang Y; Wu H; Zhu L; Yuan B; Qiao Y; Lu J; Liu K; Dong Z; Jin G; Chen X; Zhao J
Neoplasia; 2021 Jul; 23(7):663-675. PubMed ID: 34144266
[TBL] [Abstract][Full Text] [Related]
13. [Preliminary study of DNA polymerase beta gene silencing by small interfering RNA in human gastric cancer BGC-823 cells].
Zhao GQ; Wang L; Dong ZM
Zhonghua Zhong Liu Za Zhi; 2008 Oct; 30(10):729-32. PubMed ID: 19173798
[TBL] [Abstract][Full Text] [Related]
14. DNA Polymerase Beta Germline Variant Confers Cellular Response to Cisplatin Therapy.
Nemec AA; Abriola L; Merkel JS; de Stanchina E; DeVeaux M; Zelterman D; Glazer PM; Sweasy JB
Mol Cancer Res; 2017 Mar; 15(3):269-280. PubMed ID: 28074003
[TBL] [Abstract][Full Text] [Related]
15. [Mechanism of DNA polymerase beta hyper-expression in malignant transformation induced by benzo[a] pyrene].
Zhao W; Wu M; Yang M; Zhang ZZ
Sichuan Da Xue Xue Bao Yi Xue Ban; 2012 Nov; 43(6):801-6. PubMed ID: 23387201
[TBL] [Abstract][Full Text] [Related]
16. The K167I variant of DNA polymerase β that is found in Esophageal Carcinoma patients impairs polymerase activity and BER.
Wang Y; Zang W; Du Y; Chen X; Zhao G
Sci Rep; 2015 Nov; 5():15986. PubMed ID: 26527528
[TBL] [Abstract][Full Text] [Related]
17. Growth arrest DNA damage-inducible gene 45 gamma expression as a prognostic and predictive biomarker in hepatocellular carcinoma.
Ou DL; Shyue SK; Lin LI; Feng ZR; Liou JY; Fan HH; Lee BS; Hsu C; Cheng AL
Oncotarget; 2015 Sep; 6(29):27953-65. PubMed ID: 26172295
[TBL] [Abstract][Full Text] [Related]
18. Targeted radiosensitization of cells expressing truncated DNA polymerase {beta}.
Neijenhuis S; Verwijs-Janssen M; van den Broek LJ; Begg AC; Vens C
Cancer Res; 2010 Nov; 70(21):8706-14. PubMed ID: 20978197
[TBL] [Abstract][Full Text] [Related]
19. Identification and characterization of stemlike cells in human esophageal adenocarcinoma and normal epithelial cell lines.
Zhao R; Quaroni L; Casson AG
J Thorac Cardiovasc Surg; 2012 Nov; 144(5):1192-9. PubMed ID: 22980068
[TBL] [Abstract][Full Text] [Related]
20. Stemness and chemotherapeutic drug resistance induced by EIF5A2 overexpression in esophageal squamous cell carcinoma.
Yang H; Li XD; Zhou Y; Ban X; Zeng TT; Li L; Zhang BZ; Yun J; Xie D; Guan XY; Li Y
Oncotarget; 2015 Sep; 6(28):26079-89. PubMed ID: 26317793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
